Centivax is a clinical-stage biotechnology company based in South San Francisco, California, developing broad-spectrum vaccines to prevent infectious diseases at scale. Its lead program is a universal, broadly protective influenza vaccine in Phase 1 clinical development designed to protect against all strains of the virus. - View it on GitHub